Selected research
Industry Growth & Trends
Global Isotopes for Nuclear Medicine Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Isotopes for Nuclear Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Isotopes for Nuclear Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Isotopes for Nuclear Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Isotopes for Nuclear Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Isotopes for Nuclear Medicine market include Urenco, SHINE Medical, NTP Radioisotopes, Northwest Medical Isotopes, Medical Isotopes, ITM, CMR and Cambridge Isotope Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Isotopes for Nuclear Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Isotopes for Nuclear Medicine market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Isotopes for Nuclear Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Isotopes for Nuclear Medicine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Isotopes for Nuclear Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Isotopes for Nuclear Medicine Market by Company
Urenco
SHINE Medical
NTP Radioisotopes
Northwest Medical Isotopes
Medical Isotopes
ITM
CMR
Cambridge Isotope Laboratories
Isotopes for Nuclear Medicine Segment by Type
Stable Isotope
Radioisotope
Isotopes for Nuclear Medicine Segment by Application
Hospital
Laboratory
Others
Isotopes for Nuclear Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isotopes for Nuclear Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Isotopes for Nuclear Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isotopes for Nuclear Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Isotopes for Nuclear Medicine companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Stable Isotope
- Radioisotope
Applications
- Hospital
- Laboratory
- Others
Companies covered
- Urenco
- SHINE Medical
- NTP Radioisotopes
- Northwest Medical Isotopes
- Medical Isotopes
- ITM
- CMR
- Cambridge Isotope Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Isotopes for Nuclear Medicine Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Isotopes for Nuclear Medicine Market Size by Region (2021-2032)
- 1.4.1 Global Isotopes for Nuclear Medicine Market Size by Region (2021-2026)
- 1.4.2 Global Isotopes for Nuclear Medicine Market Size by Region (2027-2032)
- 1.5 Key Regions Isotopes for Nuclear Medicine Market Size (2021-2032)
- 1.5.1 North America Isotopes for Nuclear Medicine Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Isotopes for Nuclear Medicine Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Isotopes for Nuclear Medicine Market Size Growth Rate (2021-2032)
- 1.5.4 South America Isotopes for Nuclear Medicine Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Isotopes for Nuclear Medicine Market Size Growth Rate (2021-2032)
2 Isotopes for Nuclear Medicine Market by Type
- 2.1 Type Introduction
- 2.1.1 Stable Isotope
- 2.1.2 Radioisotope
- 2.2 Global Isotopes for Nuclear Medicine Market Size by Type
- 2.2.1 Global Isotopes for Nuclear Medicine Market Size Overview by Type (2021-2032)
- 2.2.2 Global Isotopes for Nuclear Medicine Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Isotopes for Nuclear Medicine Market Size Forecasted by Type (2027-2032)
- 2.3 Global Isotopes for Nuclear Medicine Market Size by Regions
- 2.3.1 North America Isotopes for Nuclear Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Isotopes for Nuclear Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Isotopes for Nuclear Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Isotopes for Nuclear Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Isotopes for Nuclear Medicine Market Size Breakdown by Type (2021-2026)
3 Isotopes for Nuclear Medicine Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Laboratory
- 3.1.3 Others
- 3.2 Global Isotopes for Nuclear Medicine Market Size by Application
- 3.2.1 Global Isotopes for Nuclear Medicine Market Size Overview by Application (2021-2032)
- 3.2.2 Global Isotopes for Nuclear Medicine Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Isotopes for Nuclear Medicine Market Size Forecasted by Application (2027-2032)
- 3.3 Global Isotopes for Nuclear Medicine Market Size by Regions
- 3.3.1 North America Isotopes for Nuclear Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Isotopes for Nuclear Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Isotopes for Nuclear Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Isotopes for Nuclear Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Isotopes for Nuclear Medicine Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Isotopes for Nuclear Medicine Industry Trends
- 4.2 Isotopes for Nuclear Medicine Industry Drivers
- 4.3 Isotopes for Nuclear Medicine Industry Opportunities and Challenges
- 4.4 Isotopes for Nuclear Medicine Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Isotopes for Nuclear Medicine Revenue (2021-2026)
- 5.2 Global Isotopes for Nuclear Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Isotopes for Nuclear Medicine Key Company Headquarters & Area Served
- 5.4 Global Isotopes for Nuclear Medicine Company, Product Type & Application
- 5.5 Global Isotopes for Nuclear Medicine Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Isotopes for Nuclear Medicine Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Isotopes for Nuclear Medicine Players Market Share by Revenue in 2025
- 5.6.3 2025 Isotopes for Nuclear Medicine Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Urenco
- 6.1.1 Urenco Company Information
- 6.1.2 Urenco Business Overview
- 6.1.3 Urenco Isotopes for Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Urenco Isotopes for Nuclear Medicine Product Portfolio
- 6.1.5 Urenco Recent Developments
- 6.2 SHINE Medical
- 6.2.1 SHINE Medical Company Information
- 6.2.2 SHINE Medical Business Overview
- 6.2.3 SHINE Medical Isotopes for Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 SHINE Medical Isotopes for Nuclear Medicine Product Portfolio
- 6.2.5 SHINE Medical Recent Developments
- 6.3 NTP Radioisotopes
- 6.3.1 NTP Radioisotopes Company Information
- 6.3.2 NTP Radioisotopes Business Overview
- 6.3.3 NTP Radioisotopes Isotopes for Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 NTP Radioisotopes Isotopes for Nuclear Medicine Product Portfolio
- 6.3.5 NTP Radioisotopes Recent Developments
- 6.4 Northwest Medical Isotopes
- 6.4.1 Northwest Medical Isotopes Company Information
- 6.4.2 Northwest Medical Isotopes Business Overview
- 6.4.3 Northwest Medical Isotopes Isotopes for Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Northwest Medical Isotopes Isotopes for Nuclear Medicine Product Portfolio
- 6.4.5 Northwest Medical Isotopes Recent Developments
- 6.5 Medical Isotopes
- 6.5.1 Medical Isotopes Company Information
- 6.5.2 Medical Isotopes Business Overview
- 6.5.3 Medical Isotopes Isotopes for Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Medical Isotopes Isotopes for Nuclear Medicine Product Portfolio
- 6.5.5 Medical Isotopes Recent Developments
- 6.6 ITM
- 6.6.1 ITM Company Information
- 6.6.2 ITM Business Overview
- 6.6.3 ITM Isotopes for Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 ITM Isotopes for Nuclear Medicine Product Portfolio
- 6.6.5 ITM Recent Developments
- 6.7 CMR
- 6.7.1 CMR Company Information
- 6.7.2 CMR Business Overview
- 6.7.3 CMR Isotopes for Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 CMR Isotopes for Nuclear Medicine Product Portfolio
- 6.7.5 CMR Recent Developments
- 6.8 Cambridge Isotope Laboratories
- 6.8.1 Cambridge Isotope Laboratories Company Information
- 6.8.2 Cambridge Isotope Laboratories Business Overview
- 6.8.3 Cambridge Isotope Laboratories Isotopes for Nuclear Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Cambridge Isotope Laboratories Isotopes for Nuclear Medicine Product Portfolio
- 6.8.5 Cambridge Isotope Laboratories Recent Developments
7 North America
- 7.1 North America Isotopes for Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Isotopes for Nuclear Medicine Market Size by Country (2021-2026)
- 7.3 North America Isotopes for Nuclear Medicine Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Isotopes for Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Isotopes for Nuclear Medicine Market Size by Country (2021-2026)
- 8.3 Europe Isotopes for Nuclear Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Isotopes for Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Isotopes for Nuclear Medicine Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Isotopes for Nuclear Medicine Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Isotopes for Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Isotopes for Nuclear Medicine Market Size by Country (2021-2026)
- 10.3 South America Isotopes for Nuclear Medicine Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Isotopes for Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Isotopes for Nuclear Medicine Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Isotopes for Nuclear Medicine Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst